Oculis Holding AG (OCS)
13.14
+0.84
(+6.88%)
USD |
NASDAQ |
Jun 03, 16:00
12.90
-0.24
(-1.79%)
After-Hours: 19:59
Oculis EPS Diluted (Quarterly) : -0.625 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.654 |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | -2.339 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.82M |
| Total Expenses (Quarterly) | 36.82M |
| Enterprise Value | 468.65M |
| Earnings Yield | -16.29% |
| Normalized Earnings Yield | -15.35 |